Negative cooperativity drives activity of capsid-directed antivirals against hepatitis B virus
Science Advances · 2026-06-12 · 12 (24)
DOI: 10.1126/sciadv.aed6483 ↗At a glance
Journal article in Science Advances, published on 2026-06-12. Written by Caleb J Valkner and 12 co-authors. Institution: Molecular and Cellular Biochemistry Department, Indiana University-Bloomington, Bloomington, IN 47405, USA. Major MEDLINE topics: Hepatitis B virus, Antiviral Agents, Capsid, Capsid Proteins. Cited 3 times so far (Crossref); 77 references. The full text is freely available in PubMed Central. Funded by: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (original language)
Hepatitis B virus capsid protein plays a role in almost every step of viral replication, from self-assembly to genome release. This makes capsid protein an attractive target for antiviral development. Capsid assembly modulators (CAMs) are direct-acting antivirals that bind capsid protein, leading to empty or aberrant complexes instead of an infectious virus. CAMs can also disrupt the capsid, preventing new infection. To understand CAM activity, we examined the energetics of CAM-capsid interaction. We observed negative cooperativity of CAM-binding kinetics and thermodynamics. These correlate with large changes in capsid architecture that presage capsid rupture. We propose that CAMs induce an accumulated strain on the capsid. Understanding the interplay of forces and architecture will help guide the development of CAMs.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Molecular and Cellular Biochemistry Department, Indiana University-Bloomington, Bloomington, IN 47405, USA.
- Chemistry Department, Indiana University-Bloomington, Bloomington, IN 47405, USA.
- Door Pharmaceuticals LLC, Bloomington, IN 47405, USA.
- Department of Cell and Biological Systems, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.
ORCID profiles: Caleb J Valkner, Nora Gibes, Marina Sicheng Xie, Smita Nair, Balasubramanian Venkatakrishnan, Irina Tsvetkova, Angela Patterson, Joseph Che-Yen Wang, Adam Zlotnick
Funding
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
Cite
APA
Valkner, C. J., Gibes, N., Xie, M. S., Nair, S., Kumar, S., Francis, S., Venkatakrishnan, B., Tsvetkova, I., Patterson, A., VanNieuwenhze, M., Dragnea, B., Wang, J. C., & Zlotnick, A. (2026). Negative cooperativity drives activity of capsid-directed antivirals against hepatitis B virus. Science Advances, 12(24). https://doi.org/10.1126/sciadv.aed6483
Vancouver
Valkner CJ, Gibes N, Xie MS, Nair S, Kumar S, Francis S, et al. Negative cooperativity drives activity of capsid-directed antivirals against hepatitis B virus. Science Advances. 2026;12(24). doi:10.1126/sciadv.aed6483
BibTeX
@article{Valkner2026,
author = {Valkner, Caleb J and Gibes, Nora and Xie, Marina Sicheng and Nair, Smita and Kumar, Shiv and Francis, Samson and Venkatakrishnan, Balasubramanian and Tsvetkova, Irina and Patterson, Angela and VanNieuwenhze, Michael and Dragnea, Bogdan and Wang, Joseph Che-Yen and Zlotnick, Adam},
title = {Negative cooperativity drives activity of capsid-directed antivirals against hepatitis B virus},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {24},
doi = {10.1126/sciadv.aed6483}
}
EUVIMED